Clinical Trials Sponsored by Hospital Felicio Rocho

Total 303 results

Hospital Felicio Rocho

Suspended

Gore Tex Implants in the Treatment of Atrophic Rhinitis (RA)

Atrophic Rhinitis
Hospital Felicio Rocho

Active, not recruiting

Effectiveness of Sequential Eustachian Tube Maneuvers in Hyperbaric Oxygen Conditions

Barotrauma;Ear | Tympanum; Perforation

Brazil
Febico Biomedical Corp.
National Taiwan University Hospital

Recruiting

To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization

Hepatocellular Carcinoma

Taiwan
Hospital de San Carlos Dr. Benicio Arzola Medina

Completed

Bupivacaine Versus Bupivacaine Plus Lidocaine in Infraclavicular Block

Postoperative Pain | Analgesia | Pain, Acute

Chile
University Hospital, Montpellier
Hopital Saint Roch

Unknown

Prilocaine or Bupivacaine for Spinal Anesthesiain Pregnant (Césarcaïne)

Cesarean

France
Hopital Saint Roch

Completed

Lactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?

Sepsis

France
Oulu University Hospital
Roche Diagnostics

Recruiting

AMH for the Identification of PCOM in PCOS Diagnosis (HARMONIA)

Polycystic Ovary Syndrome

Finland
Singapore General Hospital
Roche Diagnostics

Active, not recruiting

N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus (PISCES)

Heart Failure | Cardiovascular Complication | Type2diabetes

Singapore
Rennes University Hospital
Roche Diagnostics

Completed

Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics (ISTCAT)

Anticoagulant | Mild Head Injury | Antiplatelet

France
Massachusetts General Hospital
Roche-Genentech

Completed

Tocilizumab Plus a Short Prednisone Taper for GCA

Giant Cell Arteritis

United States
Karolinska University Hospital
Roche Diagnostics

Active, not recruiting

Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II (STROKESTOP II)

Stroke | Atrial Fibrillation

Sweden
Hospital Samaritano Paulista
Roche Diagnostics

Completed

IN-HOspital Program to systematizE Chest Pain Protocol (IN-HOPE) (In-Hope)

Chest Pain | Acute Coronary Syndrome

Brazil
Xijing Hospital
Roche Pharma AG

Unknown

Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer (MACRO)

Breast Cancer | Triple Negative Breast Cancer | Capecitabine

China
Nantes University Hospital
Roche Diagnostics

Recruiting

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding (METRODEC)

Endometrial Neoplasms | Uterine Hemorrhage | Postmenopause | Cancer Biomarker | CA 125 Antigen

France
University Hospital, Brest
Roche Chugai

Completed

Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE

Polymyalgia Rheumatica

France
Massachusetts General Hospital
Roche Diagnostics

Completed

Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting. (PROTECT)

Congestive Heart Failure

United States
University Hospital, Antwerp
Roche Diagnostics GmbH

Not yet recruiting

The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia

Bloodstream Infection

Belgium
Massachusetts General Hospital
Roche Diagnostics GmbH

Recruiting

Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure (PREFER-HF)

Cardiovascular Risk Factor | Heart Failure With Reduced Ejection Fraction | Heart Failure With Normal Ejection Fraction | Heart Failure, Right Sided | Heart Failure With Mid Range Ejection Fraction

United States
University Hospital, Tours
Roche Pharma AG

Completed

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation (RITUX-ERAH)

Humoral Rejection in Kidney Transplantation

France
Rennes University Hospital
Roche Pharma AG

Completed

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer (ANTiCIPe)

Stage IIIb and IV Non Small Cell Lung Cancer

France
University Hospital, Limoges
Hoffmann-La Roche

Terminated

Renal Graft Function After Treatment With Erythropoietin (EPO) (FRETEP)

Ischemia

France
University Hospital, Tours
Roche Pharma AG

Unknown

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation (RITUX-ERAH)

Graft Rejection

France
University Hospital, Grenoble
Roche Pharma AG

Completed

Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB (EPOetCEC)

Myocardial Ischemia

France
University Hospital, Bonn
Hoffmann-La Roche

Terminated

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

HIV Infections | Chronic Hepatitis B

Germany
University Hospital, Ghent
Hoffmann-La Roche

Completed

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

Cytomegalovirus Infections

Belgium
University Hospital, Limoges
Hoffmann-La Roche

Completed

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM (CINAM)

Chronic Hepatitis C

France
University Hospital, Bordeaux
Hoffmann-La Roche

Completed

Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients (PEGARI)

Hepatitis C, Chronic | HCV Infection

France
University Hospital Freiburg
Hoffmann-La Roche

Completed

A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty

Corneal Transplantation

Germany
Tameside General Hospital
Roche Diagnostic Ltd.

Not yet recruiting

Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study) (CHARM-D)

Diabetes Mellitus

United Kingdom
University Hospital, Bordeaux
Roche Pharma AG

Recruiting

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years (PRO-COG)

Multiple Sclerosis, Primary Progressive

France
University Hospital, Lille
Hoffmann-La Roche

Completed

Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) (VISMONEO)

Basal Cell Carcinoma

France
Aarhus University Hospital
Roche Pharma AG

Enrolling by invitation

Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients (MonAlec)

Lung Cancer | ALK Gene Mutation | Resistance, Disease | Mutation

Denmark
University Hospital, Bordeaux
Roche Pharma AG

Completed

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma (RITALLO)

Lymphoma, Follicular | Stem Cell Transplantation

France
University Hospital, Limoges
Hoffmann-La Roche

Completed

Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood (NEPHRUTIX)

Childhood Idiopathic Nephrotic Syndrome

France, Belgium
University Hospital, Limoges
Hoffmann-La Roche

Completed

Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a (DNA-EVAL)

Chronic Hepatitis B

France
Gangnam Severance Hospital
Roche Pharma AG

Unknown

HBsAg Related Response Guided Therapy (S-RGT)

Hepatitis B, Chronic

Korea, Republic of
University Hospital, Ghent
Roche Pharma AG

Completed

Evaluation of the BRADA and ABILHAND Questionnaires

Rheumatoid Arthritis

Belgium
University Hospital, Limoges
Hoffmann-La Roche

Unknown

Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients

Kidney Transplant Recipients

France
University Hospital Muenster
Hoffmann-La Roche

Completed

Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

Bullous Pemphigoid

Germany
University Hospital Muenster
Hoffmann-La Roche

Terminated

MMF and Calcineurin Inhibitor Withdrawal in CAN

Kidney Failure, Chronic | Kidney Transplantation | Immunosuppressive Agents
St. Antonius Hospital
Roche Diagnostics GmbH

Recruiting

Biomarkers in Perioperative Management (BIGPROMISE)

Quality of Life | Postoperative Complications | Death

Netherlands
Hoffmann-La Roche
Norwegian Radium Hospital

Completed

A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

Breast Cancer

Norway
University Hospital, Ghent
Roche Pharma AG

Completed

Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study (CD4-01)

Kidney Transplantation

Belgium
Lund University Hospital
Hoffmann-La Roche

Completed

Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. (ACT2)

Colorectal Cancer

Sweden, Denmark
University Hospital, Limoges
Hoffmann-La Roche

Completed

Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer (TARSEQ)

Non Small Cell Lung Cancer

France
Lund University Hospital
Hoffmann-La Roche

Completed

Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva (ACT)

Metastatic Colorectal Cancer

Denmark, Sweden
University Hospital, Rouen
Hoffmann-La Roche

Terminated

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules (AMPHORE)

HIV Infections | HIV1 Infection

France
University Hospital Tuebingen
Hoffmann-La Roche

Completed

Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Primary Gastric Diffuse-Large B-Cell Lymphoma

Germany
University Hospital Muenster
Hoffmann-La Roche

Unknown

CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.

Psoriasis

Germany
University Hospital, Saarland
Hoffmann-La Roche

Unknown

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Hepatitis C, Chronic

Clinical Trials Sponsored by Hospital Felicio Rocho

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations